Lee, Hans C.
Shah, Jatin J.
Feng, Lei
Manasanch, Elisabet E.
Lu, Rebecca
Morphey, Ashley
Crumpton, Brandon
Patel, Krina K.
Wang, Michael L. http://orcid.org/0000-0001-9748-5486
Alexanian, Raymond
Thomas, Sheeba K.
Weber, Donna M.
Orlowski, Robert Z.
Article History
Received: 3 June 2019
Revised: 11 September 2019
Accepted: 17 September 2019
First Online: 1 October 2019
Conflict of interest
: H.C.L has received consulting fees from Amgen Inc, Celgene Inc., Janssen Pharmaceutical, and Takeda Pharmaceutical and research support from Amgen Inc, Celgene, Inc., Daiichi Sankyo, Janssen Pharmaceutical, Prothena Corporation, Eutropics Pharmaceuticals, and Takeda Pharmaceutical. J.J.S. is an employee of Karyopharm Therapeutics. E.E.M. has received consulting fees from Takeda, Celgene, and Sanofi and research support from Sanofi, Quest Diagnostics, Novartis, JW Pharma, and Merck. K.K.P. has received consulting fees from Janssen Pharmaceutical, Bristol-Myers Squibb, Takeda Pharmaceutical, Celgene Inc., Precision Bio, Nektar, and Oncopeptides and research support from Celgene Inc, Poseida Therapeutics Inc., Cellectis, Janssen Pharmaceutical, and Takeda Pharmaceutical. M.L.W. has received research support from Pharmacyclics LLC, an AbbVie Company, and Janssen and honorarium from Janssen Pharmaceutical. S.K.T. has received consulting fees from Amgen Inc. and research support from Acerta Pharma, Amgen Inc., Array BioPharma, Bristol-Myers-Squibb, Celgene Inc., and Idera Inc. R.Z.O. has received consulting fees from Amgen Inc, Bristol-Myers-Squibb, Celgene Inc, Janssen Pharmaceutical, Kite Pharma, Sanofi and Takeda Pharmaceutical and research support from Amgen Inc, BioTheryX and Spectrum Pharmaceuticals. L.F., R.L., A.M., F.T., R.A., and D.M.W. declare that they have no conflict of interest.